E.E. Geduld’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

E.E. Geduld’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$242K	Buy	+50,000	New	+$1.48M	0.14%	62
2016 Q1	–	Sell	-5,000	Closed	-$393K	–	208
2015 Q4	$393K	Sell	5,000 -1,500	-23%	-$86.7K	0.24%	45
2015 Q3	$263K	Buy	+6,500	New	+$344K	0.25%	86
2014 Q1	–	Sell	-25,000	Closed	-$809K	–	348
2013 Q4	$809K	Sell	25,000 -25,917	-51%	-$769K	0.39%	50
2013 Q3	$1.51M	Buy	+50,917	New	+$1.44M	0.92%	14

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

E.E. Geduld's ISEE Position: Q4 2016 in Review

E.E. Geduld opened a new position in IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016: 50,000 shares worth $242K. The stake represents 0.14% of the portfolio and ranks #62 among its holdings. This is a return to the name: E.E. Geduld previously reported a position in ISEE as recently as Q4 2015.

E.E. Geduld first reported a position in ISEE in Q3 2013 and has held it in 5 quarters since. The position peaked at $1.51M in Q3 2013. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

E.E. Geduld held 50,000 shares of IVERIC bio, Inc. Common Stock worth $242K as of Q4 2016.
IVERIC bio, Inc. Common Stock was a new E.E. Geduld position in Q4 2016.
IVERIC bio, Inc. Common Stock made up 0.14% of E.E. Geduld's portfolio in Q4 2016, its #62 holding.
E.E. Geduld first reported a position in IVERIC bio, Inc. Common Stock in Q3 2013 and has held it in 5 quarters since.
E.E. Geduld's IVERIC bio, Inc. Common Stock position peaked at $1.51M in Q3 2013.
137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on E.E. Geduld's 13F filing for Q4 2016, filed 8 Feb 2017.